Treatment of Recurrent Metastatic Colon Cancer in the Age of Modern Adjuvant Therapy

Overview

Journal Clin Colorectal Cancer

Publisher Elsevier

Specialties Gastroenterology
Oncology

Date 2008 Sep 17

PMID 18794064

Citations 5

Authors

Carla Kurkjian

Anthony J Murgo

Shivaani Kummar

Affiliations

Soon will be listed here.

Abstract

The treatment of patients with metastatic colon cancer has evolved tremendously over the past 10 years, with improved overall survival (OS) rates as a result of the advent of several important agents. Following the results of important adjuvant trials, the incorporation of oxaliplatin into the adjuvant setting has significantly increased the disease-free survival and OS rates in patients who undergo curative resection. However, still a significant number of patients will present with recurrent disease after being treated with oxaliplatin-containing chemotherapy regimens. Herein, we present approaches to the chemotherapeutic management of such patients with a review of the literature.

Citing Articles

Combination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer model.

Vo M, Nguyen-Pham T, Lee H, Lakshmi T, Yang S, Jung S Oncotarget. 2017; 8(16):27252-27262.

PMID: 28460478 PMC: 5432332. DOI: 10.18632/oncotarget.15917.

Palliative oxaliplatin-based chemotherapy after exposure to oxaliplatin in the adjuvant setting for colon cancer.

Peixoto R, Kumar A, Lim H J Gastrointest Oncol. 2015; 6(5):487-91.

PMID: 26487941 PMC: 4570922. DOI: 10.3978/j.issn.2078-6891.2015.033.

MiR-339-5p regulates the growth, colony formation and metastasis of colorectal cancer cells by targeting PRL-1.

Zhou C, Liu G, Wang L, Lu Y, Yuan L, Zheng L PLoS One. 2013; 8(5):e63142.

PMID: 23696794 PMC: 3656035. DOI: 10.1371/journal.pone.0063142.

Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease.

Vickers M, Bar J, Gorn-Hondermann I, Yarom N, Daneshmand M, Hanson J Clin Exp Metastasis. 2011; 29(2):123-32.

PMID: 22120473 DOI: 10.1007/s10585-011-9435-3.

Inhibition of Anchorage-Independent Proliferation and G0/G1 Cell-Cycle Regulation in Human Colorectal Carcinoma Cells by 4,7-Dimethoxy-5-Methyl-l,3-Benzodioxole Isolated from the Fruiting Body of Antrodia camphorate.

Lien H, Lin H, Wang Y, Chen L, Yang D, Lai Y Evid Based Complement Alternat Med. 2009; 2011:984027.

PMID: 19293251 PMC: 3137876. DOI: 10.1093/ecam/nep020.